Skip to main content
OpenTrials

Clinical trial condition

Slow Virus Diseases

Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.

2,616 public trials 184 recruiting studies
Refine in advanced search Browse all conditions

Slow Virus Diseases trial results

Completed

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

NCT00814879

Conditions
AIDS, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, +16 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Saint Raphael Healthcare System New Haven, Connecticut, United States
  • Waterbury Hospital Waterbury, Connecticut, United States
  • VA CT Healthcare Systems West Haven, Connecticut, United States
View Trial Details
Completed

Dose Optimisation of Stavudine for the Treatment of HIV Infection

NCT02670772

Conditions
Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations
  • VHS-YRG Care Medical Centre Chennai, Tamil Nadu, India
  • Charlotte Maxeke Johannesburg Academic Hospital Johannesburg, Gauteng, South Africa
  • The Infectious Disease Institute (IDI), Mulago Hospital Complex Kampala, Uganda
View Trial Details
Completed

A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.

NCT01328041

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Beverly Hills, California, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 89 locations
View Trial Details
Completed

Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

NCT01495702

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Spectrum Medical Group Phoenix, Arizona, United States
  • AHF Research Center Beverly Hills, California, United States
  • Pacific Oak Medical Group Beverly Hills, California, United States
  • Kaiser Permanente Hayward, California, United States
View all 80 locations
View Trial Details

Related conditions